Status:
COMPLETED
Registry Study of ID & IDA in Korean Patients With Heart Failure
Lead Sponsor:
JW Pharmaceutical
Conditions:
Iron Deficiency Anemia
Eligibility:
All Genders
Brief Summary
The prevalence of Iron Deficiency and Iron Deficiency Anemia in Korean HF patient
Detailed Description
Epidemiological study to assess The prevalence of ID (Iron Deficiency) \& IDA (Iron Deficiency Anemia) in Korean patients with heart failure
Eligibility Criteria
Inclusion
- more than 19 years old
- Informed Consent Form
- Hear Failure criteria as belows
- Heart Failure Sign(more than 1 Sx such as fatigue, dyspnea, ankle swelling)
- Heart Failure Symptom(more than 1 among Jugular venous pressure (JVP) elevation, pulmonary crackle, peripheral edema) ③ Lung congestion or edema at chest X-ray ④ Objective findings of structural or functional cardiac abnormality(more than abnormality level of BNP or NT-proBNP, abnormality of echocardiography )
Exclusion
- Not applicable
Key Trial Info
Start Date :
January 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
465 Patients enrolled
Trial Details
Trial ID
NCT04812873
Start Date
January 30 2019
End Date
August 31 2020
Last Update
March 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, South Korea